Sofosbuvir/Velpatasvir

Overview of attention for article published in Annals of Pharmacotherapy, October 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 5,825 followers.

RT @beatrizmpdm: Sofosbuvir/Velpatasvir The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C https://t.co/FewTy6Nvn5

Sofosbuvir/Velpatasvir The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C https://t.co/FewTy6Nvn5

RT @theannals: Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C: Objective... https://t.c…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.